FortuneOne of the most shorted stocks on the market just leapt 99%, putting a 'rib-crunching' squeeze on bearish bettors16 days agoAngel Adegbesan & Carmen ReinickeBy Angel Adegbesan & Carmen Reinickemore_vert
CNBCNovavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker13 days agoAnnika Kim ConstantinoBy Annika Kim Constantinomore_vert
Montgomery Community MediaLocal Companies Work Together for New COVID, Flu Vaccines13 days agoSuzanne PollakBy Suzanne Pollakmore_vert
BenzingaWhy Is Novavax Stock Trading Higher On Friday? - Novavax (NASDAQ:NVAX), Sanofi (NASDAQ:SNY)16 days agoVandana SinghBy Vandana Singhmore_vert
Yahoo FinanceNovavax First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag14 days agomore_vert
BioCenturyDeals Report: Sanofi-Novavax to co-commercialize Nuvaxovid, develop combination vaccines13 days agomore_vert
MorningstarNovavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi16 days agomore_vert
STATSanofi licenses Novavax shot, Moderna RSV vaccine okay delayed- STAT16 days agoAndrew JosephBy Andrew Josephmore_vert
Business StandardNovavax signs Covid-19 license deal with Sanofi, secures business viability16 days agomore_vert
BioProcess InsiderSanofi inks $1.2bn Novavax deal to bolster post-pandemic vax sales13 days agoMillie NelsonBy Millie Nelsonmore_vert
Precision Vaccinations$1.4 Billion Transaction Leverages Matrix-M Adjuvant Vaccine Technology16 days agoDonald HackettBy Donald Hackettmore_vert
Ropes & Gray LLPClient Novavax, Maker of COVID-19 Vaccine, Signs $1.4 Billion Agreement with Sanofi | News & Events17 days agomore_vert
BioWorld OnlineNovavax storms back with $1.2B Sanofi deal16 days agoLee LandenbergerBy Lee Landenbergermore_vert
The Business JournalsNovavax's share price surges after inking co-licensing deal with pharma giant16 days agoDrew HansenBy Drew Hansenmore_vert
PR NewswireNovavax Reports First Quarter 2024 Financial Results and Operational Highlights16 days agomore_vert
SaltwireNovavax shares soar on license deal with Sanofi at lofty valuation16 days agoPatrick Wingrove & Bhanvi SatijaBy Patrick Wingrove & Bhanvi Satijamore_vert
WTOPMaryland-based Novavax soars on big vaccine deal16 days agoJeff ClabaughBy Jeff Clabaughmore_vert
The Motley FoolIf You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now10 days agoAdria CiminoBy Adria Ciminomore_vert
FiercePharmaSanofi pays $1.2B to partner with Novavax on COVID-19 vaccine16 days agoKevin DunleavyBy Kevin Dunleavymore_vert
GlobeNewswirePress Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 ...16 days agomore_vert
Proactive Investors USANovavax shares skyrocket after billion-dollar licensing deal with Sanofi16 days agoAngela Harmantas & Emily JarvieBy Angela Harmantas & Emily Jarviemore_vert
BenefitsProNovavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine13 days agomore_vert
MM+M OnlineSanofi strikes licensing pact with Novavax for COVID, flu-COVID combo shots16 days agoJack O'BrienBy Jack O'Brienmore_vert
Pharmaceutical TechnologySanofi signs $1.2bn licensing agreement for Novavax’s Covid-19 vaccine16 days agomore_vert
Financial TimesSanofi licensing deal doubles value of vaccine group Novavax16 days agoOliver BarnesBy Oliver Barnesmore_vert
BioSpaceNovavax Soars on $1.4B Deal With Sanofi for COVID Vaccine16 days agoKate GoodwinBy Kate Goodwinmore_vert
The Wall Street JournalNovavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal16 days agomore_vert
InvestopediaNovavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines16 days agoAaron McDadeBy Aaron McDademore_vert
QuartzNovavax stock skyrockets 120% on $1.2 billion Sanofi vaccine deal16 days agoRocio FabbroBy Rocio Fabbromore_vert
FX EmpireNovavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?11 days agoCarolane De PalmasBy Carolane De Palmasmore_vert
Investor's Business DailyNovavax Rockets 125% On Sanofi Covid Vaccine Agreement16 days agoAlan R. ElliottBy Alan R. Elliottmore_vert
Investing.comNovavax shares price target raised on Sanofi deal13 days agoNatashya AngelicaBy Natashya Angelicamore_vert
Zacks Investment ResearchNovavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal13 days agomore_vert
Reuters.comNovavax shares soar on license deal with Sanofi at lofty valuation14 days agoPatrick Wingrove & Bhanvi SatijaBy Patrick Wingrove & Bhanvi Satijamore_vert
Yahoo FinanceNovavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates12 days agomore_vert
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company16 days agoAnjalee KhemlaniBy Anjalee Khemlanimore_vert
BloombergNovavax (NVAX) Shares Soar on $1.2 Billion Sanofi Vaccine Licensing Deal16 days agoTim LohBy Tim Lohmore_vert